| scholarly article | Q13442814 |
| P2093 | author name string | E J Kim | |
| J S Park | |||
| S E Namkoong | |||
| S J Um | |||
| H J Kwon | |||
| E S Hwang | |||
| P2860 | cites work | Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity | Q24599944 |
| Mammalian Ras interacts directly with the serine/threonine kinase Raf | Q27860833 | ||
| The MHC-encoded TAP1/LMP2 bidirectional promoter is down-regulated in highly oncogenic adenovirus type 12 transformed cells | Q28581797 | ||
| Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo | Q28609049 | ||
| The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
| The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth | Q33292242 | ||
| The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors | Q35199113 | ||
| Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. | Q35870318 | ||
| Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions | Q35976941 | ||
| Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours | Q35979112 | ||
| Mitochondrial translocation contact sites: separation of dynamic and stabilizing elements in formation of a TOM-TIM-preprotein supercomplex | Q39962397 | ||
| Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes | Q40064324 | ||
| Adenovirus E1A represses transcription of the cellular JE gene | Q40100964 | ||
| A new version of the two-hybrid assay for detection of protein-protein interactions | Q40393329 | ||
| Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. | Q40407855 | ||
| MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation | Q40807437 | ||
| The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. | Q40944954 | ||
| Regulation of type I interferon gene expression by interferon regulatory factor-3. | Q41063455 | ||
| How viral oncogenes make the cell cycle | Q41078321 | ||
| A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein | Q41415390 | ||
| Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. | Q41460849 | ||
| Suppression of tumor formation in vivo by expression of the JE gene in malignant cells | Q41680734 | ||
| Viral strategies of immune evasion | Q41735903 | ||
| Protein Domains Governing Interactions Between E2F, the Retinoblastoma Gene Product, and Human Papillomavirus type 16 E7 Protein | Q41818217 | ||
| E7-specific cytotoxic T cell tolerance in HPV-transgenic mice | Q45193974 | ||
| Retinoic acid receptors interact physically and functionally with the T:G mismatch-specific thymine-DNA glycosylase | Q47724741 | ||
| Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression | Q47954784 | ||
| Human papillomaviruses and genital cancer | Q70189965 | ||
| An in vitro assay of beta-galactosidase from yeast | Q71467218 | ||
| Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas | Q77849562 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | evasion of host immune response | Q1660157 |
| carcinogenesis | Q1637543 | ||
| P304 | page(s) | 6764-9 | |
| P577 | publication date | 2000-03-10 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis | |
| P478 | volume | 275 |
| Q39663814 | A Novel Cytoplasmic Adaptor for Retinoic Acid Receptor (RAR) and Thyroid Receptor Functions as a Derepressor of RAR in the Absence of Retinoic Acid* |
| Q42817732 | Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. |
| Q40047932 | Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection |
| Q33633839 | Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy. |
| Q35057804 | BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer |
| Q34468787 | Biological activities and molecular targets of the human papillomavirus E7 oncoprotein |
| Q37277976 | Biomarkers in cervical cancer |
| Q44764278 | Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts |
| Q92592825 | Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy |
| Q37350422 | Cellular and molecular biological aspects of cervical intraepithelial neoplasia |
| Q34153620 | Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications |
| Q38748682 | Cervical cancer: A comprehensive approach towards extermination |
| Q81317317 | Characterization of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis |
| Q37724792 | DNA damage response is hijacked by human papillomaviruses to complete their life cycle |
| Q34457888 | Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7 |
| Q34326864 | Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells |
| Q38960064 | Diverse mechanisms evolved by DNA viruses to inhibit early host defenses |
| Q35116264 | E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes |
| Q41488084 | Efficacy and Tolerability of Polyphenon E in "Difficult-to-Treat" Multiple Genital Warts in an HIV-Positive Male Subject |
| Q55176441 | Efficacy and Tolerability of Topical Green Tea Extract (Polyphenon E) Application in a “Therapy-Resistant” Plantar Wart. |
| Q36179672 | Emerging therapies for human papillomavirus infection |
| Q38598051 | Epigenetic Alterations in Human Papillomavirus-Associated Cancers |
| Q35940596 | Epithelial cell responses to infection with human papillomavirus |
| Q28076194 | Evasion of host immune defenses by human papillomavirus |
| Q34895151 | Evasion of host immunity directed by papillomavirus-encoded proteins |
| Q33930412 | Examination of the pRb-dependent and pRb-independent functions of E7 in vivo |
| Q38082753 | Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis |
| Q42802737 | Functional dissection of the transactivation domain of interferon regulatory factor-1 |
| Q24290998 | Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins |
| Q39946489 | Functional mapping of the human papillomavirus type 16 E1 cistron |
| Q26997399 | Genomic landscape of human papillomavirus-associated cancers |
| Q104459077 | HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway |
| Q37410888 | HPV vaccination: the beginning of the end of cervical cancer? - A Review. |
| Q33841838 | HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs |
| Q34117485 | Hepatitis C virus and interferon resistance |
| Q40475356 | High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. |
| Q33808063 | High-Risk Human Papillomavirus E7 Alters Host DNA Methylome and Represses HLA-E Expression in Human Keratinocytes |
| Q28084802 | High-risk human papillomavirus targets crossroads in immune signaling |
| Q38725533 | High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression |
| Q34479356 | Histone acetyltransferases as regulators of nonhistone proteins: the role of interferon regulatory factor acetylation on gene transcription |
| Q38019133 | Histone deacetylases in viral infections |
| Q47159047 | How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery |
| Q26822621 | Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies |
| Q34743768 | Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response |
| Q35784727 | Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence |
| Q58279986 | Human papillomavirus and cervical cancer |
| Q37315925 | Human papillomavirus and molecular considerations for cancer risk |
| Q33851664 | Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes |
| Q34309947 | Human papillomavirus in head and neck cancer. |
| Q37769103 | Human papillomavirus oncoproteins: pathways to transformation |
| Q24295849 | Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes |
| Q45158133 | Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes |
| Q33292435 | Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner |
| Q36550902 | Human papillomaviruses and cervical cancer |
| Q34208269 | Human papillomaviruses and the interferon response |
| Q56959307 | Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis |
| Q33579936 | IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes |
| Q92679819 | IL-6 expression promoted by Poly(I:C) in cervical cancer cells regulates cytokine expression and recruitment of macrophages |
| Q40669880 | IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo |
| Q31046841 | Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo |
| Q42030463 | Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression. |
| Q34570129 | Immune evasion in human papillomavirus-associated cervical cancer |
| Q40060642 | Immune evasion mechanisms of human papillomavirus: An update |
| Q40045752 | Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy |
| Q90565961 | Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression |
| Q42657689 | Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression |
| Q39769389 | Integrity of a HPV11 infection cell model and identification of (-)-Epigallocatechin-3-gallate as a potential HPV11 inhibitor |
| Q38509739 | Interaction between interferon regulatory factor-1 and human papillomavirus E7 oncogene in cervical cancer: an ontology study |
| Q28566098 | Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300 |
| Q24305508 | Interaction of the HPV E7 proteins with the pCAF acetyltransferase |
| Q38714309 | Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism |
| Q39744237 | Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes |
| Q55162579 | Interferon regulatory factor 1 inactivation in human cancer. |
| Q41652681 | Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration |
| Q53309083 | Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. |
| Q45855880 | Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors |
| Q33595431 | Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. |
| Q91994556 | Key Molecular Events in Cervical Cancer Development |
| Q73695498 | Long-term follow-up of patients treated with recombinant human interferon gamma for cervical intraepithelial neoplasia |
| Q39003287 | Manipulation of the innate immune response by human papillomaviruses |
| Q57064814 | Mechanisms of persistence by small DNA tumor viruses |
| Q27002467 | Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection |
| Q39361627 | MicroRNAs in HPV associated cancers: small players with big consequences |
| Q35545566 | Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. |
| Q24679243 | Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus |
| Q35902272 | Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade |
| Q64097188 | Molecular mechanisms in progression of HPV-associated cervical carcinogenesis |
| Q36303426 | Molecular mechanisms of human papillomavirus-induced carcinogenesis. |
| Q37610446 | Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation |
| Q37316158 | Oncogenic activities of human papillomaviruses |
| Q92715593 | Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System |
| Q33839638 | Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes |
| Q53377599 | Papillomaviruses: a correlation between immune evasion and oncogenicity? |
| Q34349416 | Pathogenesis of human papillomaviruses in differentiating epithelia |
| Q38347114 | Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. |
| Q40499640 | Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes |
| Q35620080 | Prevention of cervical cancer through papillomavirus vaccination |
| Q54745506 | Quantitative multiplex real-time PCR for the sensitive detection of interferon β gene induction and viral suppression of interferon β expression |
| Q41918717 | RNASeq analysis of differentiated keratinocytes reveals a massive response to late events during human papillomavirus type 16 infection, including loss of epithelial barrier function |
| Q36284493 | Recent advances in the search for antiviral agents against human papillomaviruses. |
| Q35606176 | Recent advances in the study of HPV-associated carcinogenesis |
| Q38370782 | Recent progress in vaccination against human papillomavirus-mediated cervical cancer |
| Q55982769 | Recurrent respiratory papillomatosis |
| Q26700093 | Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6 |
| Q24293755 | Regulation of immunity and oncogenesis by the IRF transcription factor family |
| Q36579274 | Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. |
| Q36381224 | Role of proteomics in translational research in cervical cancer |
| Q94677099 | Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer |
| Q35192650 | Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance |
| Q90398112 | Suppression of a Subset of Interferon-Induced Genes by Human Papillomavirus Type 16 E7 via a Cyclin Dependent Kinase 8-Dependent Mechanism |
| Q43577063 | The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway |
| Q90197682 | The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response |
| Q41888239 | The IRF family of transcription factors: Inception, impact and implications in oncogenesis |
| Q28079490 | The Importance of Physiologically Relevant Cell Lines for Studying Virus-Host Interactions |
| Q40444191 | The Interaction Between Human Papillomaviruses and the Stromal Microenvironment |
| Q90270888 | The Interplay between Antiviral Signalling and Carcinogenesis in Human Papillomavirus Infections |
| Q38365107 | The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy |
| Q46142571 | The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic. |
| Q33609914 | The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus |
| Q37010892 | The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. |
| Q37617163 | The biological properties of E6 and E7 oncoproteins from human papillomaviruses. |
| Q37808166 | The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication |
| Q40769186 | The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes |
| Q47562558 | The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling. |
| Q37325199 | The human papillomavirus E7 oncoprotein |
| Q39000409 | The human papillomavirus E7 oncoprotein as a regulator of transcription |
| Q40734787 | The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex |
| Q36707747 | The innate antiviral response: new insights into a continuing story |
| Q38126455 | The interplay between HPV and host immunity in head and neck squamous cell carcinoma |
| Q36541450 | The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system |
| Q58798155 | The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1 |
| Q37198662 | The papillomavirus E7 proteins |
| Q37449263 | The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis |
| Q38211087 | The role of inflammation in cervical cancer |
| Q37952807 | The tug-of-war between dendritic cells and human chronic viruses |
| Q37418916 | Therapeutic vaccines against human papillomavirus and cervical cancer |
| Q33292114 | Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine |
| Q34151939 | Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens. |
| Q36607707 | Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma |
Search more.